ConductScience.org, home

Paper28294295

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Giuliano AE and 8 others. CA Cancer J Clin, 2017. Cited by 764 papers, by iCite.

Cite this record

ConductScience Library. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. Papers, record 28294295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28294295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
PubMed
Journal
CA Cancer J Clin
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
764
iCite
Relative citation ratio, by iCite
29.3
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giuliano AEArmando E
2Connolly JLJames L
3Edge SBStephen B
4Mittendorf EAElizabeth A
5Rugo HSHope S
6Solin LJLawrence J
7Weaver DLDonald L
8Winchester DJDavid J
9Hortobagyi GNGabriel N

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Neoplasm StagingMajor topic
Biomarkers, Tumor
Female
Humans
Lymphatic Metastasis
Neoplasm Metastasis
Practice Guidelines as Topic
Prognosis
United States

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30CA016672NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07003009Immun Checkpoint Washout in Patients With Invasive Ductal Breast CancerResults

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in28689371Erratum: Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.https://conductscience.org/library/papers/28689371

Source PubMed

Download CSV of comments and corrections

Cited by515

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 764 citations.

PMIDTitleJournalYearIn PapersSource
42955120Characterizing potential subgroups and predictive factors of cancer-related fatigue among breast cancer patients through latent profile analysis and machine learning algorithms.Support Care Cancer2026https://conductscience.org/library/papers/42955120PubMed
42941313Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes.J Clin Med2026https://conductscience.org/library/papers/42941313PubMed
42930205Association Between the Number of Invasive Tumor Foci and Axillary Nodal Burden in Multifocal and Multicentric Breast Cancer.Curr Oncol2026https://conductscience.org/library/papers/42930205PubMed
42920161Advancing women's health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment.Arch Public Health2026https://conductscience.org/library/papers/42920161PubMed
42890536New insights into tumor size in colorectal cancer: smaller size, higher risk?Front Oncol2026https://conductscience.org/library/papers/42890536PubMed
42811741Optimizing the ER Cutoff in HER2-Positive Breast Cancer: ER ≥ 50% Predicts Low pCR Rates and Resistance to Antibody-Drug Conjugates in the Neoadjuvant Setting.Cancer Med2026https://conductscience.org/library/papers/42811741PubMed
42742922Distinct risk profiles of heart failure and non-heart failure major adverse cardiovascular events among patients with early breast cancer: a competing-risk analysis.Int J Clin Oncol2026https://conductscience.org/library/papers/42742922PubMed
42731006[Sentinel node biopsy and lymphatic mapping from a nuclear medicine perspective: principles, methods and experiences in Szeged].Magy Onkol2026https://conductscience.org/library/papers/42731006PubMed
42598618Clear cell Paget disease with underlying malignancy: A case report and review of literature.Radiol Case Rep2026https://conductscience.org/library/papers/42598618PubMed
42578630Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.Acta Oncol2026https://conductscience.org/library/papers/42578630PubMed
42540580The role of body mass index and tumor necrosis factor α in breast cancer development: a case-control study.Arch Med Sci2026https://conductscience.org/library/papers/42540580PubMed
42516134Risk factors for radiation pneumonitis following adjuvant radiotherapy for breast cancer: a retrospective cohort study.Front Oncol2026https://conductscience.org/library/papers/42516134PubMed
42513228Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Molecules2026https://conductscience.org/library/papers/42513228PubMed
42512804HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort.Medicina (Kaunas)2026https://conductscience.org/library/papers/42512804PubMed
42403201BI-RADS v2025 for breast ultrasound: key updates and Asian perspectives.Ultrasonography2026https://conductscience.org/library/papers/42403201PubMed
42399903Plexin A2 regulated the metastasis in breast cancer through MCM7.BMC Cancer2026https://conductscience.org/library/papers/42399903PubMed
42393102Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer.NPJ Breast Cancer2026https://conductscience.org/library/papers/42393102PubMed
42323696Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer.Breast Cancer Res2026https://conductscience.org/library/papers/42323696PubMed
42322704Thermal ablation for early-stage breast cancer: cryoablation, microwave ablation, radiofrequency ablation, high-intensity focused ultrasound ablation, and laser ablation - a systematic review.Breast2026https://conductscience.org/library/papers/42322704PubMed
42319488Automatic metabolic breast cancer staging using [¹⁸F]FDG PET/CT: comparison with nuclear medicine physician-based and clinical staging.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42319488PubMed

See all 515 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28294295

GET https://conductscience.org/api/papers/v1/28294295/cited_by?page=2